Symposium: Progress on Achieving the Global Strategy for Controlling Chromoblastomycosis

The Global Chromoblastomycosis Working Group (GCWG) invites you to join an engaging session on chromoblastomycosis to provide updates on achieving activities identified to address chromoblastomycosis, a neglected tropical disease, globally. The GCWG was formed in 2024 to lead control efforts of chromoblastomycosis including the development of a global strategy. The GCWG will host this workshop to discuss ongoing initiatives that align with the GCWG global strategy, and provide novel data on epidemiological, diagnostic, clinical, and laboratory aspects of chromoblastomycosis. Topics to be discussed include diagnosing chromoblastomycosis at the primary care level and decentralized sites, the development and role of epidemiological cutoff values for chromoblastomycosis-causing fungi, antifungal susceptibility testing using muriform bodies (sclerotic cells), therapeutic options including newer azoles and topical immunomodulators, monitoring for geographical spread of climate-sensitive causative organisms, and defining the true burden of disease through quality of life and disability studies.

We look forward to welcoming you and your participation!

Organizing Committee:
Global Chromoblastomycosis Working Group